Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

15.0K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
15.0K
Comparing Copy Number Variations and SNPs02:26

Comparing Copy Number Variations and SNPs

18.4K
Sequencing of the human genome has opened up several best-kept secrets of the genome. Scientists have identified thousands of genome variations that exist within a population. These variations can be a single nucleotide or a larger chromosomal variation.
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
18.4K
Histone Variants at the Centromere02:30

Histone Variants at the Centromere

4.7K
Histone variants are the histone proteins with structural and sequence variations. These variants may be regarded as “mutant” forms that replace their canonical histone counterparts in the nucleosomes. Specific post-translational modifications on the histone variants enable further chromatin complexity and regulate tissue-specific gene expression. The most common histone variants are from histone H2A, H2B, and linker histone H1 families. However, several variants of histone H3...
4.7K
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

5.8K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
5.8K
Single Nucleotide Polymorphisms-SNPs01:05

Single Nucleotide Polymorphisms-SNPs

17.5K
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
17.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Plasma exosomal HERV-K transcripts are increased in amyotrophic lateral sclerosis.

BMC neuroscience·2026
Same author

The Motor Neuron Disease Register for England, Wales, and Northern Ireland: Protocol for a Population Register.

JMIR research protocols·2026
Same author

CYP2D6 variants in amyotrophic lateral sclerosis: an association study of risk and survival.

Brain : a journal of neurology·2026
Same author

Gut microbiota and ALS: cause, consequence or correlation? - a systematic review.

Frontiers in neuroscience·2026
Same author

La benchmarking large language models for extracting biobank-derived insights into health and disease.

PLoS computational biology·2026
Same author

Large-scale exome analyses reveal new rare variant contributions in amyotrophic lateral sclerosis.

Nature genetics·2026

Related Experiment Video

Updated: Nov 27, 2025

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease
09:34

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease

Published on: April 4, 2018

34.4K

Rare Variant Burden Analysis within Enhancers Identifies CAV1 as an ALS Risk Gene.

Johnathan Cooper-Knock1, Sai Zhang2, Kevin P Kenna3

  • 1Sheffield Institute for Translational Neuroscience (SITraN), University of Sheffield, Sheffield, UK.

Cell Reports
|December 2, 2020
PubMed
Summary

Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease. New research identifies genetic variations in CAV1/CAV2 enhancers linked to ALS, suggesting CAV1/CAV2 overexpression as a potential therapeutic target.

Keywords:
CAV1CAV2amyotrophic lateral sclerosisgene enhancersmembrane lipid raftsnon-coding DNAwhole-genome sequencing

More Related Videos

Genetic Variant Detection in the CALR gene using High Resolution Melting Analysis
08:46

Genetic Variant Detection in the CALR gene using High Resolution Melting Analysis

Published on: August 26, 2020

5.1K
Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation
07:15

Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation

Published on: January 16, 2019

11.2K

Related Experiment Videos

Last Updated: Nov 27, 2025

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease
09:34

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease

Published on: April 4, 2018

34.4K
Genetic Variant Detection in the CALR gene using High Resolution Melting Analysis
08:46

Genetic Variant Detection in the CALR gene using High Resolution Melting Analysis

Published on: August 26, 2020

5.1K
Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation
07:15

Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation

Published on: January 16, 2019

11.2K

Area of Science:

  • Neurodegenerative diseases
  • Genetics and genomics
  • Cellular biology

Background:

  • Amyotrophic lateral sclerosis (ALS) is an incurable neurodegenerative disease.
  • CAV1 and CAV2 proteins are crucial for membrane lipid rafts (MLRs), supporting cell signaling and neuronal survival.
  • Overexpression of CAV1 has previously shown promise in ameliorating ALS phenotypes in vivo.

Purpose of the Study:

  • To identify pathogenic genetic variations within enhancer elements regulating gene expression in ALS.
  • To investigate the role of identified variations in CAV1/CAV2 expression and MLR function.
  • To explore CAV1 as a potential ALS risk gene and therapeutic target.

Main Methods:

  • Development and application of a pipeline to identify genetic variations in enhancer elements.
  • Replication of findings in an independent patient cohort.
  • Analysis of CAV1/CAV2 expression and MLR disruption in patient-derived cells.
  • CRISPR-Cas9 perturbation studies in neurons.

Main Results:

  • Disease-associated variations were identified within CAV1/CAV2 enhancers, replicating in an independent cohort.
  • These enhancer mutations were found to reduce CAV1/CAV2 expression and disrupt MLRs in patient cells.
  • CRISPR-Cas9 editing near a patient mutation confirmed reduced CAV1/CAV2 expression in neurons.
  • Enrichment of ALS-associated mutations within CAV1 exons further implicates CAV1 as an ALS risk gene.

Conclusions:

  • Genetic variations in CAV1/CAV2 enhancers contribute to ALS pathogenesis by reducing gene expression and disrupting MLRs.
  • CAV1 is identified as a significant risk gene for ALS.
  • CAV1/CAV2 overexpression presents a potential personalized medicine strategy for treating ALS.